Erasca Quote - ERAS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.60

Bid

2.60

Ask

2.80

Volume

0.00 Day's Range 0.00

1.51 52 Week Range 3.45

Market Cap

735.091M

Previous Close

2.60

Open

Last Trade

2.6

Last Trade Time

04:55:15

Financial Volume

VWAP

Average Volume (3m)

1,932,279

Shares Outstanding

282,727,282

Dividend Yield

PE Ratio

-5.88

Earnings Per Share (EPS)

-0.44

Revenue

Net Profit

-125.04M

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.erasca.com

Headquarters

Wilmington, Delaware, USA

Founded

Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was US$2.60. Over the last year, Erasca shares have traded in a share price range of US$ 1.51 to US$ 3.45.

Erasca currently has 282,727,282 shares outstanding. The market capitalization of Erasca is US$735.09 million. Erasca has a price to earnings ratio (PE ratio) of -5.88.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.22	-7.80141843972	2.82	2.94	2.51	1353176	2.68302523	CS
4	-0.06	-2.25563909774	2.66	3.305	2.44	1724957	2.86194826	CS
12	-0.25	-8.77192982456	2.85	3.305	2.41	1932279	2.82700362	CS
26	0.25	10.6382978723	2.35	3.45	1.96	2122089	2.70372272	CS
52	0.34	15.0442477876	2.26	3.45	1.51	1649432	2.46471192	CS
156	-15.54	-85.6670341786	18.14	18.34	1.51	1031178	4.07229303	CS
260	-13.3	-83.6477987421	15.9	24.47	1.51	964230	4.76700365	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WCTWellchange Holdings Company Limited	US$ 2.37 (89.60%)	18.24M
VRPXVirpax Pharmaceuticals Inc	US$ 1.04 (76.36%)	18.14M
SJWSJW Group	US$ 87.99 (58.97%)	94
NSTSNSTS Bancorp Inc	US$ 17.72 (58.36%)	8
LIFWMSP Recovery Inc	US$ 2.16 (45.95%)	4.22M
KELYAKelly Services Inc	US$ 7.11 (-48.92%)	7
ENTAEnanta Pharmaceuticals Inc	US$ 5.01 (-46.19%)	117
FNWBFirst Northwest Bancorp	US$ 6.01 (-45.71%)	2
WAFDWaFd Inc	US$ 21.82 (-39.97%)	30
CLBKColumbia Financial Inc	US$ 11.52 (-36.67%)	4
WCTWellchange Holdings Company Limited	US$ 2.37 (89.60%)	18.24M
VRPXVirpax Pharmaceuticals Inc	US$ 1.04 (76.36%)	18.14M
BENFBeneficient	US$ 1.04 (18.18%)	9.31M
RGTIRigetti Computing Inc	US$ 1.73 (16.89%)	8.64M
ELABElevai Labs Inc	US$ 0.0199 (-1.49%)	7.01M